Botulinum toxin therapy: functional silencing of salivary disorders.

Related Articles

Botulinum toxin therapy: functional silencing of salivary disorders.

Acta Otorhinolaryngol Ital. 2017 Apr;37(2):168-171

Authors: Lovato A, Restivo DA, Ottaviano G, Marioni G, Marchese-Ragona R

Abstract
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary fistulae that may have a post-traumatic or post-operative origin. BTX injections can be considered in sialoceles and salivary fistulae after the failure of or together with conservative treatments (e.g. antibiotics, pressure dressings, or serial aspirations). BTX treatment has a promising role in chronic sialadenitis. BTX therapy is highly successful in the treatment of gustatory sweating (Frey's syndrome), and could be considered the gold standard treatment for this neurological disorder.

PMID: 28516981 [PubMed - in process]

http://ift.tt/2rnZFx0